Right now, Ozempic is used for type 2 diabetes and is sometimes prescribed off-label for prediabetes. If you purchase this medicine without insurance, it’s expensive — around $850–900 per month. However, the clinics are experienced with prior authorizations, and if the medicine is approved by the patient’s insurance after that process, the cost can drop to approximately $25–30 per month. When it becomes available in the weight-loss dosing of 2.4 mg, the price is still unknown. Some insurance plans may cover it, but unfortunately others will not.
Ozempic (semaglutide) was first introduced as a diabetes drug. Metformin has been the mainstay treatment for diabetes and pre-diabetes for at least 20 years. We often use Ozempic in combination with Metformin, as they complement each other: both help reduce blood sugar levels, decrease liver glucose output, and support weight loss.
Read more: Ozempic Face: See How Weight Loss Transforms Celebrity Faces
US price guidelines (out-of-pocket) for brand-name versions and alternatives
| Drug* | Active Ingredient / Class | Starting Dose | Approx. Monthly Cost (U.S., no insurance) per month |
|---|---|---|---|
| Ozempic | Semaglutide (GLP-1 agonist) | 0.25 mg SC once weekly | $900–1,200 |
| Wegovy | Semaglutide (GLP-1 agonist) | 0.25 mg SC once weekly | $1,300–1,500+ |
| Rybelsus | Semaglutide (oral) | 3 mg orally once daily | $900–1,100 |
| Mounjaro | Tirzepatide (GIP/GLP-1) | 2.5 mg SC once weekly | $1,000–1,200+ |
| Zepbound | Tirzepatide | 2.5 mg SC once weekly | $1,300–1,500+ |
| Trulicity | Dulaglutide (GLP-1 agonist) | 0.75 mg SC once weekly | $500–800 (up to ~$1,000) |
| Victoza | Liraglutide (GLP-1 agonist) | 0.6 mg SC once daily | $500–800 |
| Compounded semaglutide | Non-branded semaglutide | Varies (often ~0.25 mg SC weekly) | ~$200+ (varies widely) |
* Key Considerations
- Insurance coverage: many patients pay far less than list price if covered.
- Compounded semaglutide: cheaper, but not FDA-approved — risks with quality and accuracy of dosing.
- Dosing and indication: Prices vary based on weekly vs. monthly pens, and whether prescribed for diabetes or weight loss.
- Indication differences: Some drugs (e.g., Ozempic, Rybelsus) are officially for type 2 diabetes, while Wegovy/Zepbound are approved for obesity.
To summarize: Ozempic (semaglutide) is currently approved for diabetes and pre-diabetes with a maximum dose of 1 mg per day. Recent studies with up to 2.4 mg have shown significant weight loss results. At Scottsdale Weight Loss, in addition to prescribing Ozempic, we also use aggressive diets, exercise counseling, and classes. Combined, these approaches can help patients lose at least 10–15% of their weight with the medication alone, and even more when paired with a structured diet program.
Author: Emily Carter
Senior Health Editor & Market Analyst Emily specializes in plastic surgery trends and implant technology. Her work focuses on analyzing FDA reports and patient satisfaction data to help readers understand the technical side of breast and body contouring procedures.
